Severe bleeding risk of direct oral anticoagulants versus vitamin K antagonists for stroke prevention and treatment in patients with atrial fibrillation: a systematic review …

W Xu, M Lv, S Wu, S Jiang, Z Zeng, Z Fang… - … Drugs and Therapy, 2023 - Springer
Purpose We aimed to determine the safety of direct oral anticoagulants (DOACs) for stroke
prevention and treatment in patients with atrial fibrillation (AF). Methods A systematic search …
被引用次数：10 相关文章

Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic …

W Xu, M Lv, S Wu, S Jiang, Z Zeng, Z Fang… - … Drugs and Therapy, 2021 - europepmc.org
We aimed to determine the safety of direct oral anticoagulants (DOACs) for stroke prevention
and treatment in patients with atrial fibrillation (AF). A systematic search of four databases …

Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic …

W Xu, M Lv, S Wu, S Jiang, Z Zeng… - … Drugs & Therapy, 2023 - search.ebscohost.com
Purpose: We aimed to determine the safety of direct oral anticoagulants (DOACs) for stroke
prevention and treatment in patients with atrial fibrillation (AF). Methods: A systematic search …

Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic …

W Xu, M Lv, S Wu, S Jiang, Z Zeng… - … drugs and therapy, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose We aimed to determine the safety of direct oral anticoagulants (DOACs) for stroke
prevention and treatment in patients with atrial fibrillation (AF). Methods A systematic search …